Trial Profile
A Randomized, Double-Blind Study to Evaluate the Safety and Effectiveness of the Exhale Drug-Eluting Stent in Homogeneous Emphysema Subjects With Severe Hyperinflation.
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 27 Jan 2011
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Emphysema; Restenosis
- Focus Therapeutic Use
- Acronyms EASE
- Sponsors Broncus Technologies
- 05 May 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 29 Jul 2008 New trial record.